AMS Israel develops protein-free tissue adhesives based on proprietary alga-mimetic formulations for use in a wide range of surgical applications. The company's adhesive technology mimics the underwater adherence mechanism of algae.
AMS's first product, Seal-V, is a surgical sealant designed for use in various vascular procedures. Seal-V has proven to be safe, effective, cost effective, strong, biocompatible, biodegradable, and easy to use. Seal-V can adhere to both native and synthetic vessels, positioning it as a solution to control bleeding in vascular surgeries.
The company's other products include Seal-G, a gastrointestinal bioresorbable sealant designed to secure gastrointestinal anastomoses to decrease lethal complications resulting from postsurgical leaks, and the Orthopedic Adhesion Barrier, an extra-articular bioresorbable gel designed to speed the recovery of injured joints by preventing tissue adhesions, thereby reducing disabling complications following surgical or nonsurgical joint injuries.
AMS Israel's technology has been developed under the umbrella of the Alfred Mann Institute at the Technion. In 2018, the company received the CE mark for its Seal-G surgical sealant for gastrointestinal procedures.